Dr Ross Macdonald is the CEO of Cynata Therapeutics Limited. Qualified with both a PhD and a business degree, he has 30 years’ experience and a track record of success in pharmaceutical and biotechnology businesses. Specifically, he has stewarded many medical discoveries through clinical development to eventual global commercial application.
Advanced Therapies and Regenerative Medicine Day 2 - Thursday 17th May 2018 @ 11:40
Clinical development of the world’s first iPSC-derived MSC therapeutic product
Experience gained from conducting the world’s first clinical trial of an allogeneic, iPSC-derived cell therapy product
New, second-generation approach to manufacturing therapeutic MSCs that provides a robust, consistent product without reliance upon multiple donors
Progress toward delivering a successful product for graft-versus-host disease and potentially other targets.